ORGO News and Press, Organogenesis Holdings Inc. From 03/02/22

Gainers: Organogenesis (NASDAQ:ORGO) +24%. CytomX Therapeutics (NASDAQ:CTMX) +13%. X4 Pharmaceuticals (NASDAQ:XFOR) +13%. MannKind (NASDAQ:MNKD) +10%. Allied Healthcare (NASDAQ:AHPI) +6%. Losers: Karyopharm Therapeutics (NASDAQ:KPTI) -31%. Bright Health Grou...

Image source: The Motley Fool. Organogenesis Holdings Inc. (NASDAQ: ORGO) Q4 2021 Earnings Call Mar 01, 2022 , 5:00 p.m. ET Operator Continue reading For further details see: Organogenesis Holdings Inc. (ORGO) Q4 2021 Earnings Call Transc...

Organogenesis Holdings Inc. (ORGO) Q4 2021 Earnings Conference Call March 1, 2022 17:00 ET Company Participants Gary Gillheeney - President and Chief Executive Officer Dave Francisco - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Danielle Antalffy - SVB Leerink S...

Organogenesis Holdings press release (NASDAQ:ORGO): Q4 GAAP EPS of $0.39 beats by $0.29. Revenue of $128.56M (+20.4% Y/Y) beats by $4.19M. For further details see: Organogenesis Holdings GAAP EPS of $0.39 beats by $0.29, revenue of $128.56M beats by $4.19M

CANTON, Mass., March 01, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, t...

CANTON, Mass., Feb. 17, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...

The subsector with the best value and quality scores is pharmaceutical/biotechnology. Life science tools and healthcare equipment are the most overvalued. Fast facts on IDNA. A list of cheap stocks. For further details see: IDNA: Healthcare Dashboard For February

CANTON, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, toda...

CANTON, Mass., Feb. 07, 2022 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...

The recent market pullback was arguably overdue and is already making stocks attractive for longer-term investors. Insiders are giving excellent industry signals to act on and numerous specific stocks to consider. Take your pick of insider-approved energy, bank, income, infrastruc...